TTK Healthcare is currently trading at Rs. 575.90, down by 57.70 points or 9.11% from its previous closing of Rs. 633.60 on the BSE.
The scrip opened at Rs. 650.05 and has touched a high and low of Rs. 663.40 and Rs. 566.60 respectively. So far 219787 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 633.60 on 24-May-2013 and a 52 week low of Rs. 334.50 on 19-Jun-2012.
Last one week high and low of the scrip stood at Rs. 633.60 and Rs. 500.45 respectively. The current market cap of the company is Rs. 456.33 crore.
The promoters holding in the company stood at 65.43% while Institutions and Non-Institutions held 4.40% and 30.18% respectively.
TTK Healthcare reported results for the fourth quarter and year ended March 31, 2013.
The company has reported a fall of 39.52% in its net profit at Rs 2.25 crore in Q4FY13 as compared to net profit of Rs 3.72 crore in the same quarter previous year. Total income from operation of the company has decreased by 2.45% to Rs 85.91 crore as compared to Rs 88.07 crore in corresponding quarter last year.
For the year ended March 31, 2013, the company has registered 9.15% fall in its net profit at Rs 14.20 crore in FY13 as against Rs 15.63 crore in previous years. Total income from operation of the company has decreased to Rs 382.30 crore as compared to Rs 353.74 crore in FY12, up by 8.07%.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1830.20 |
Dr. Reddys Lab | 1183.00 |
Cipla | 1549.65 |
Lupin | 2094.65 |
Zydus Lifesciences | 887.70 |
View more.. |